|
⚲
|
| Keyboard |
| Neal Fowler | |
|---|---|
| Firm | |
| Address | c/o Liquidia Technologies, Inc 419 Davis Drive, Suite 100 Morrisville, NC 27560 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Liquidia Technologies Inc | 021-357336 | Executive Officer | 22.4 M of 22.4 M |
||
| Liquidia Technologies Inc | 021-305952 | Executive Officer | 25.5 M of 53.3 M |
||
| Envisia Therapeutics Inc | 021-259444 | Director | 10.1 M of 16.5 M |
||
| Aralez Pharmaceuticals Inc | 021-257798 | Director | 75.0 M of 75.0 M |
||
| Envisia Therapeutics Inc | 021-249607 | Director | 4.6 M of 5.1 M |
||
| LQ3 Pharmaceuticals Inc | 021-221630 | Director | 2.4 M of 10.0 M |
||
| Envisia Therapeutics Inc | 021-206825 | Executive Officer | 15.2 M of 69.4 M |
||
| Liquidia Technologies Inc | 021-156174 | Executive Officer | 13.8 M of 13.8 M |
||
| Liquidia Technologies Inc | 021-78167 | Executive Officer | 25.0 M of 25.0 M |
||